Related Experiment Video
Updated: Jul 2, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Setting:
We recently showed that treatment failure rate was higher among multidrug-resistant tuberculosis (MDR-TB) patients without a previous history of tuberculosis (TB) treatment, or so-called 'primary resistance'.
Objective:
To investigate the phosphorylation levels of signal transducers and activators of transcription-1 (STAT-1) and STAT-4 and the subsequent cytokine release as a possible cause of a poor prognosis in MDR-TB patients with primary resistance.
Design:
Ten patients with successfully treated pulmonary TB without resistance, 12 MDR-TB patients with acquired resistance and 10 MDR-TB patients with primary resistance were enrolled. After 24 h stimulation of peripheral blood mononuclear cells (PBMC) with interferon-gamma (IFN-gamma), interleukin-12 (IL-12), purified protein derivative (PPD), or lysate of Mycobacterium tuberculosis, flow cytometric analysis of intracellular pSTAT-1 and pSTAT-4 were performed and secretion of IFN-gamma, IL-12p40 and tumour necrosis factor-alpha (TNF-alpha) was measured in culture supernatant.
Results:
The mean fluorescent intensities of pSTAT-1 and pSTAT-4 in PBMC of MDR-TB patients with primary resistance decreased on stimulation of IFN-gamma, PPD or lysate of M. tuberculosis when compared with patients with acquired resistance. In addition, secretion of IFN-gamma, IL-12p40 and TNF-alpha in these patients decreased on various stimuli.
Conclusion:
Decreased phosphorylation of STAT-1, STAT-4, and of subsequent cytokine release, might be associated with a poor prognosis in MDR-TB patients with primary resistance.
Insights
Multidrug-resistant tuberculosis (MDR-TB) patients with primary resistance show decreased STAT-1 and STAT-4 phosphorylation and reduced cytokine release, potentially explaining their poor prognosis. This impacts understanding of MDR-TB treatment outcomes.
Area of Science:
- Immunology
- Infectious Diseases
- Molecular Biology
Background:
- Multidrug-resistant tuberculosis (MDR-TB) treatment failure is higher in patients with primary resistance (no prior TB treatment).
- Signal transducer and activator of transcription (STAT) pathways and cytokine release are crucial in immune responses to tuberculosis.
Purpose of the Study:
- To investigate STAT-1 and STAT-4 phosphorylation and subsequent cytokine release in MDR-TB patients with primary resistance.
- To determine if these molecular changes contribute to the poor prognosis observed in this patient group.
Main Methods:
- Enrolled 32 patients: 10 treated TB, 12 MDR-TB with acquired resistance, 10 MDR-TB with primary resistance.
- Stimulated peripheral blood mononuclear cells (PBMCs) with various antigens and cytokines (IFN-gamma, IL-12, PPD, M. tuberculosis lysate).
- Analyzed intracellular pSTAT-1 and pSTAT-4 via flow cytometry and measured cytokine secretion (IFN-gamma, IL-12p40, TNF-alpha).
Main Results:
- MDR-TB patients with primary resistance exhibited decreased pSTAT-1 and pSTAT-4 levels upon stimulation compared to those with acquired resistance.
- Reduced secretion of IFN-gamma, IL-12p40, and TNF-alpha was observed in MDR-TB patients with primary resistance across various stimuli.
- These molecular deficits were linked to the specific stimuli used in the study.
Conclusions:
- Decreased STAT-1 and STAT-4 phosphorylation in PBMCs may be associated with impaired immune responses in MDR-TB patients with primary resistance.
- Reduced cytokine release following stimulation suggests a compromised cellular immunity contributing to poor prognosis.
- These findings highlight potential molecular mechanisms underlying treatment failure in primary resistant MDR-TB.
Related Concept Videos
The JAK-STAT Signaling Pathway
Mechanism of Antibiotic Resistance in MRSA
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Clinical Significance of Antibiotic Resistance
Tuberculosis
